25-羟基维生素D、成纤维细胞生长因子23与20年随访中急性肾损伤风险
在ARIC研究12380名中年至老年社区人群中,中位随访24.3年,2145人发生需住院的急性肾损伤(AKI)。多变量Cox模型显示,最低 vs 最高四分位25-羟基维生素D的HR为1.35(95%CI 1.17-1.54),最高 vs 最低四分位FGF23的HR为1.19(95%CI 1.05-1.36),二者均与AKI风险独立相关。
要点
- 社区中老年人群中,低25-羟基维生素D与需住院AKI风险独立相关。
- 高FGF23水平亦与需住院AKI风险独立相关。
- 关联在调整肾功能、CKD或CVD后仍一致。
核心结论
- 在社区中年至老年成人中,低25-羟基维生素D和高FGF23水平均与需住院的急性肾损伤风险独立相关。
研究设计与样本
- 基于ARIC研究第2次访视(1990-1992年)的12380名参与者,平均年龄57岁,24%为黑人,采用多变量Cox模型分析。
主要发现
- 中位随访24.3年期间,2145人发生需住院的AKI,粗发病率为8.3/1000人年(95%CI 8.0-8.7)。
- 最低 vs 最高四分位25-羟基维生素D的AKI风险HR为1.35(95%CI 1.17-1.54)。
- 最高 vs 最低四分位FGF23的AKI风险HR为1.19(95%CI 1.05-1.36)。
- 关联在人口学和临床亚组中一致,且不受AKI是否为住院主要诊断影响。
- 调整 incident CKD 或 CVD 作为时变协变量后关联仍一致。
临床怎么用
- 在社区中老年人群中,可关注低25-羟基维生素D和高FGF23水平者的AKI风险,但尚无干预证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Low serum 25-hydroxyvitamin D levels have been identified as a risk factor for acute kidney injury (AKI) among critically ill patients. Whether low 25-hydroxyvitamin D levels are associated with long-term incidence of hospitalization with AKI in the general population is unknown. METHODS: Among 12,380 participants (mean age, 57 years; 24% black) in the Atherosclerosis Risk in Communities (ARIC) Study who attended visit 2 (1990-1992), we explored the association of serum 25-hydroxyvitamin D with incident hospitalization with AKI. Multivariable Cox models were used to estimate hazard ratios (HRs). We also examined the association of serum fibroblast growth factor 23 (FGF23) with AKI. RESULTS: During a median follow-up of 24.3 years, 2145 participants had incident hospitalization with AKI (crude incidence rate: 8.3; 95% confidence interval [CI]: 8.0-8.7, per 1,000 person-years). In multivariable Cox models (including adjustment for kidney function), lower 25-hydroxyvitamin D and higher FGF23 levels were each significantly associated with an increased risk of AKI (HR: 1.35; 95% CI: 1.17-1.54, for lowest vs. highest quartile for 25-hydroxyvitamin D, and HR: 1.19; 95% CI: 1.05-1.36, for highest vs. lowest quartile for FGF23). The association was consistent across demographic and clinical subgroups, regardless of whether AKI was the primary diagnosis for hospitalization, and when adjusting for incident chronic kidney disease (CKD) or cardiovascular disease (CVD) as a time-varying covariate. CONCLUSION: Among middle- to older-age adults in the community, low 25-hydroxyvitamin D and high FGF23 levels were independently associated with an increased risk of AKI. Future studies should explore underlying mechanisms linking these bone mineral metabolism markers with kidney injury.
引用
- Ishigami J, Grams ME, Michos ED, et al. 25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up. Kidney Int Rep. 2021. PMID: 34013108. doi:10.1016/j.ekir.2021.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。